Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Overuse of Antidepressant in Patients With Alzheimer Disease and Associated Disorders : An Observational Study

Authors not listed

Assistance Publique - Hôpitaux de Paris · 2015

Abstract

Near 40% of French people aged 65 years and over and suffering from Alzheimer disease and associated disorders (ADAD) are exposed to antidepressants (AD) versus 13% of those without ADAD. If depression and anxiety disorders are comorbidities frequently associated with dementia, such level of AD exposure suggests an overuse of AD in this population. Hypothesis: Overuse of AD is frequent in patients with ADAD. It is possible to assess overuse associated with off label prescriptions (no validated indication and excess in prescription duration) Main objective: to assess the prevalence of AD overuse associated with off label prescriptions (no validated indication and excess in prescription duration) in patients aged 70 years and over with ADAD. Secondary objectives: 1. To assess the prevalence of AD prescribed for a non validated indication 2. To assess the prevalence of AD prescribed with excess in prescription duration 3. To assess the prevalence of psychotropic coprescription and notably the prevalence of the neurologic iatrogenic alerts as defined by the French National Authority for Health 4. To assess factors associated to AD overuse Method: A transversal monocentric study in the geriatric day Bretonneau unit will be performed. Study will be proposed to all eligible patients (with non-opposition of the patient or of his legal representative to the collection of his personal data). Included people will have no supplementary clinical or complementary investigations. The geriatrician in charge will have to systematically collect the indication and the history of the AD treatment. At the end of the evaluation performed in the geriatric day unit, the geriatrician will have to conclude to the AD overuse or not associated with off label prescription. Doubtful case will be examined by a validation committee. Eligibility criteria: Patient consulting in geriatric day hospital with age ≥70 years and dementia according to DSMIV criteria, whatever its level and antidepressant prescription. Sample size Considering that 40% of people suffering from ADAD are prescribed antidepressant (data from French Health Insurance), the number of eligible patients consulting in the geriatric day swill be 65 in 6 months. If 10% of them are opposed to the collection of their personal data and if the overuse of AD is near 50%, precision of the result will be 12.8% (95%CI bilateral). Duration of inclusion: 6 months Duration of patient's participation: one day

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Anonymous. (2015). Overuse of Antidepressant in Patients With Alzheimer Disease and Associated Disorders : An Observational Study. <em>Assistance Publique - Hôpitaux de Paris</em>. https://clinicaltrials.gov/study/NCT02529436
Vancouver
Anonymous. Overuse of Antidepressant in Patients With Alzheimer Disease and Associated Disorders : An Observational Study. Assistance Publique - Hôpitaux de Paris. 2015.
BibTeX
@misc{anon2015Overus, title = {Overuse of Antidepressant in Patients With Alzheimer Disease and Associated Disorders : An Observational Study}, author = {Anonymous}, journal = {Assistance Publique - Hôpitaux de Paris}, year = {2015}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings